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Leishmania infantum is one of the major parasite species associated with visceral 
leishmaniasis, a severe form of the disease that can become lethal if untreated. This 
obligate intracellular parasite has developed diverse strategies to escape the host 
immune response, such as exoproducts (Exo) carrying a wide range of molecules, 
including parasite virulence factors, which are potentially implicated in early stages 
of infection. Herein, we report that L. infantum Exo and its two fractions composed 
of extracellular vesicles (EVs) and vesicle-depleted-exoproducts (VDEs) inhibit human 
peripheral blood invariant natural killer T (iNKT) cell expansion in response to their spe-
cific ligand, the glycolipid α-GalactosylCeramide (α-GalCer), as well as their capacity 
to promptly produce IL-4 and IFNγ. Using plate-bound CD1d and α-GalCer, we found 
that Exo, EV, and VDE fractions reduced iNKT cell activation in a dose-dependent man-
ner, suggesting that they prevented α-GalCer presentation by CD1d molecules. This 
direct effect on CD1d was confirmed by the observation that CD1d:α-GalCer complex 
formation was impaired in the presence of Exo, EV, and VDE fractions. Furthermore, 
lipid extracts from the three compounds mimicked the inhibition of iNKT cell activation. 
These lipid components of L. infantum exoproducts, including EV and VDE fractions, 
might compete for CD1-binding sites, thus blocking iNKT cell activation. Overall, our 
results provide evidence for a novel strategy through which L. infantum can evade 
immune responses of mammalian host cells by preventing iNKT  lymphocytes from 
recognizing glycolipids in a TCR-dependent manner.
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inTrODUcTiOn
Leishmaniasis is a neglected tropical disease caused by parasites of the genus Leishmania. These 
parasites have a complex digenetic life cycle, adopting an extracellular, flagellated, and motile form 
(promastigotes) in the insect vector and an intracellular, non-motile form (amastigotes) in the 
vertebrate host (1–3). Promastigotes, inside the mammalian host, infect phagocytic cells where they 
rapidly transform into the amastigote form that replicates, ruptures the host cell, and spreads the 
infection. The clinical manifestations of the disease vary with parasite species and host immune 
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responses, ranging from subclinical infection, and self-healing 
lesions to chronic symptoms that can ultimately lead to death 
(1–3). A successful infection depends on the different mecha-
nisms of evasion developed by the parasite, enabling it to subvert 
the immune responses and to persist in the mammalian host 
(4, 5). The main strategy consists in inducing antigenic diversion, 
which impairs both innate and adaptive immune responses (4, 5).
Recent research on new mechanisms of parasite escape has 
emphasized the capacity of Leishmania to release exoproducts 
(Exo) (6–8). We have shown that Exo can be separated into two 
fractions, namely vesicle-depleted-exoproducts (VDEs) and 
extracellular vesicles (EVs) (6). The latter, which are released 
into the extracellular environment by many types of eukaryotic 
and prokaryotic cells, are currently the focus of much interest. 
They are delimited by a lipid bilayer including specific proteins, 
lipids, and mRNA, depending on their cellular origin (9–12). 
These vesicles have been extensively studied because of their 
capacity to mediate intercellular communication that does not 
require cell-to-cell contact (9–12). In the context of infections by 
parasites, such as L. infantum, the influence of total Exo, EV, and 
VDE fractions on mammalian host immune responses is still a 
matter of debate.
Invariant natural killer T (iNKT) cells form a distinct popula-
tion of T lymphocytes with innate-like properties. They express 
an invariant TCR α-chain (Vα14-Jα18 in mice and Vα24-Jα18 
in humans) associated with a restricted set of Vβ chains, includ-
ing Vβ8, Vβ7, and Vβ2 in mice and Vβ11 in humans. Unlike 
conventional T  cells, which recognize peptide antigens in the 
context of MHC class I or II molecules, iNKT cells are restricted 
by glycolipid antigens presented by the non-polymorphic MHC 
class I-like molecule CD1d (13–16). The α-galactosylceramide 
(α-GalCer) is a potent and specific antigen that is frequently 
used in the study of iNKT cells for stimulation and identification 
by the use of α-GalCer-loaded CD1d tetramers (17). The innate-
like character of iNKT cells is revealed by their ability to rapidly 
respond to stimulation by producing a wide range of cytokines, 
such as IFNγ, IL-4, IL-17, IL-10, and IL-13, which endows these 
cells with an exceptional immunomodulatory potential (18–21). 
iNKT  cells are implicated in a number of immune responses 
including autoimmunity, tumor immunology, and immunity 
against viral, bacterial, fungal, and parasitic pathogens, namely 
Leishmania (22–29). Additionally, iNKT cells play a major role in 
patrolling the body and in mounting distinct immune responses 
to infections (30, 31).
Here, we found that exposure to Exo, EV, and VDE fractions 
led to the inhibition of human peripheral blood iNKT cell expan-
sion and cytokine production in response to α-GalCer. Starting 
from this finding, we set out to examine the mechanisms through 
which this inhibition occurred and attempted to identify the 
molecules involved as well as their mode of action.
MaTerials anD MeThODs
Parasites
A cloned line of virulent Leishmania infantum (MHOM/MA/67/
ITMAP-263) was maintained by weekly sub-passages at 26°C in 
RPMI 1640 medium supplemented with 10% heat-inactivated 
fetal bovine serum (FBS), 100 U/ml penicillin, 100 mg/ml strep-
tomycin, and 20 mM HEPES (all from Lonza). Only promastig-
otes from up to 10 passages were used in the experiments. Before 
recovery of extracellular material, parasites were transferred to 
cRPMI, a protein-deprived medium composed of RPMI base 
supplemented with SDM base and hemin, which was previously 
optimized for exosome studies (32). The starting inoculum for all 
cultures was 1 × 106 parasites/ml.
Preparation of L. infantum extracellular
Promastigotes were grown in cRPMI for 4  days as previously 
described (32). Parasites were removed from culture supernatant 
by centrifugation and filtration through a 0.4 µm filter. To recover 
the total exoproducts, the filtrated supernatant was concentrated 
in a centrifugal filter unit with a membrane nominal molecular 
weight limit (NMWL) of 3  kDa. To isolate EV, the filtrated 
supernatant was concentrated in a centrifugal filter unit with a 
NMWL of 100 kDa and ultracentrifuged overnight at 100,000 g, 
4°C. The volume that passed through was further concentrated 
in a centrifugal filter unit with a NMWL of 3 kDa, in order to 
obtain VDE. These three preparations were dialyzed twice 
against PBS using the respective filter devices and resuspended 
in PBS. Finally, each preparation was passed through a 0.2 µm 
filter. Note that 1× Exo, EV, or VDE designates products released 
from 1 × 107 parasites per microliters (Figure S1 in Supplementary 
Material).
We used EV isolated from the human pancreas adenocar-
cinoma-derived BxPC-3 cell line as a negative control (33) 
(here after termed heterologous EV or hEV). Heterologous 
EVs were prepared following the ExoQuick-TC™ instruction 
manual. Briefly, the supernatant of the BxPC-3 cell line, previ-
ously cultured in RPMI medium with exosome-free FBS, was 
collected and centrifuged 15 min at 3,000 g to remove cells and 
debris. The supernatant was then incubated overnight with the 
ExoQuick-TC™ precipitation solution at 4°C. The preparation 
was centrifuged at 1,500 g for 30 min., supernatant was discarded, 
and the hEVs were resuspended in PBS.
Biological samples
Peripheral blood mononuclear cells were collected from healthy 
donors at the Etablissement Français du Sang (EFS), Paris, France, 
and at the Immuno-haemotherapy Department of Hospital de 
São João, Porto, Portugal. Experiments were performed in 
accordance with the Helsinki Declaration, with informed 
consent received from each donor and managed by each institu-
tion. PBMCs were isolated by density-gradient centrifugation 
(Ficoll-Paque PLUS, GE Healthcare or Histopaque-1077, Sigma). 
C57BL/6J mice used for the preparation of bone marrow-derived 
dendritic cells (BM-DCs) were maintained in the animal facility 
at the Instituto de Biologia Molecular e Celular (IBMC, Porto, 
Portugal). Animals were euthanized in accordance with the 
IBMC.INEB Animal Ethics Committees and the Portuguese 
National Authorities for Animal Health guidelines (directive 
2010/63/EU).
human inKT cell expansion
Peripheral blood mononuclear cells were cultured in 24-well 
plates at a density of 106  cells per well in RPMI 1640 medium 
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containing antibiotics, 10% heat-inactivated FBS, 200  mM 
glutamine, and 10  mM HEPES (all from Invitrogen or Lonza) 
with 100  ng/ml α-GalCer (Alexis-Coger SA), as previously 
described (18, 19). When indicated, L. infantum Exo, EV, VDE, 
and hEV were added at the onset of culture. Twenty-four hours 
later, rhIL-2 (purchased from R&D or kindly provided by the 
National Cancer Institute) was added. After 8–12 days, cells were 
harvested, extensively washed, and counted using trypan blue 
dye exclusion for dead cells. Cells were further stained and ana-
lyzed by flow cytometry.
surface and intracellular staining
Fresh or cultured PBMCs were stained and analyzed by flow 
cyto metry as previously described (18, 19). Surface stain-
ing was performed in PBS buffer containing 2% FBS and 
0.01% NaN3, using PBS57-loaded-CD1d-tetramers (from the 
National Institutes of Health Tetramer Core Facility) (in all 
Figures stated as CD1d-tetramers), and the following directly 
conjugated anti-human monoclonal antibodies: PerCP-Cy5.5-
labeled anti-CD3 (OKT3), PE-Cy7-labeled anti-CD4 (RPA-T4), 
and antigen-presenting cell (APC)-labeled-anti-CD8 (RPA-T8) 
(eBioscience).
For intracellular cytokine staining, CD1d-transfected C1R 
cells were incubated with α-GalCer alone or in the presence 
of L. infantum Exo, EV, and VDE. Human iNKT cell lines and 
10  µg/ml brefeldin A (Sigma-Aldrich) were added 2  h later. 
After a 5-h incubation, cells were harvested and washed before 
fixation with 4% paraformaldehyde and permeabilization using 
1% saponin (Sigma-Aldrich). Cells were then stained with anti-
CD3, APC-labeled anti-IL-4 (8D4-8), and PE-Cy7-anti-IFNγ 
(4S.B3) (eBioscience). Data were acquired on a FACS Canto 
II flow cytometer (BD Biosciences) and analyzed with FlowJo 
software (10.2).
Detection of cD1d:α-galcer complex 
Formation
Dendritic cells (DCs) were derived from bone marrow (BM) 
precursors as previously described (34). In brief, BM precur-
sors recovered by flushing femurs and tibias from the hind 
legs of C57BL/6J mice were suspended in RPMI supplemented 
with 10% heat-inactivated FBS, 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 10  mM HEPES (all from Lonza), 50  µM 
2-Mercaptoethanol (Sigma Chemical), and 10% of J558 cell line 
supernatant containing GM-CSF (J558-GM-CSF) and cultured 
at 37°C with 5% CO2 in T75 culture flasks with a vented cap. At 
day 3, the same amount of supplemented medium was added to 
each flask. At day 6 and 8, half of the volume of each flask was 
recovered and centrifuged and the cell pellet was resuspended in 
the same amount of supplemented medium. At day 9, BM-DCs 
were harvested, washed, and cultured in RPMI 2% FBS with 
100  ng/ml α-GalCer and/or increasing doses (1, 10, 20×) of 
L. infantum Exo, EV, or VDE for 4 h. CD1d expression and forma-
tion of CD1d:α-GalCer complexes on the surface of BM-DC was 
then determined by flow cytometry using the following mAbs: 
anti-mouse CD1d (51.1) (eBioscience) and anti-mouse CD1d:α-
GalCer (L363, Biolegend).
human inKT-cell line generation  
and restimulation
A polyclonal primary iNKT cell line was generated as described 
(35) according to a previously established protocol (36). In brief, 
PBMCs from healthy donors were cultured with 100  ng/ml of 
α-GalCer (KRN7000) and 100  U/ml of IL-2 (R&D Systems). 
After 11  days, CD1d-PBS57 tetramer+CD3+ cells were sorted 
using a FACSAria cell sorter (BD Biosciences). When cells stop-
ped proliferating, 1  µg/ml of PHA (Thermo Fisher Scientific, 
Waltham, MA, USA) was added together with irradiated PBMC 
for restimulation.
inKT cell activation assays
Invariant natural killer T cell activation assays were performed 
using CD1d-transfected C1R cells as APCs or soluble mouse 
CD1d coated in 384-well plates.
For assays using APC, CD1d-transfected C1R cells were 
cultured for 4 h with 5 or 25 ng/ml of α-GalCer alone or together 
with increasing doses (1, 10, 20×) of L. infantum Exo, EV, or VDE. 
The human polyclonal primary iNKT cell line was then added 
and supernatants from this co-culture were harvest 40 h later and 
assayed for GM-CSF by ELISA using purified (BVD2-23B6) and 
biotinylated (BVD2-21C11) anti-GM-CSF mAbs (Biolegend). 
CD1d (NIH tetramer core facility) was immobilized on 384-well 
Maxisorp treated microplates (Nunc, Rochester, NY, USA). After 
overnight incubation at 37°C, a mixture of 25 or 100  ng/ml 
α-GalCer and L. infantum Exo, EV, VDE, or hEV was added for 
24 h. In some experiments, α-GalCer (25 ng/ml) was added 8 h 
before or after Exo, VDE, or EV (20×). After extensive washing, 
the 24.8 iNKT cell hybridoma (25,000/well) was added for further 
20 h. Culture supernatants were recovered, and IL-2 concentra-
tions were determined by ELISA using purified (JES6-1A12) and 
biotinylated (JES6-5H4) anti-IL-2 mAbs (Biolegend).
lipid extraction and Quantification
Total lipid content was isolated from Exo, EV, and VDE using the 
Bligh and Dyer method (37). The lower organic phase was dried 
under nitrogen at 40°C and samples were kept at −20°C until 
quantification. Total lipid content of each sample was assessed 
by the sulpho-phospho-vanillin colorimetric assay. Lipid extracts 
were solubilized in chloroform and incubated at 90°C in a heater 
block until solvent evaporation. Increasing concentrations of 
cholesterol (Sigma-Aldrich) dissolved in chloroform were treated 
similarly and used as standard. Upon addition of 96% sulfuric 
acid samples were further incubated at 90°C for 20 min and then 
cooled at 4°C for 4 min followed by the addition of 0.2 mg/ml 
vanillin in 17% phosphoric acid. The samples were then incubated 
at room temperature for 10 min and absorbance was measured at 
540 nm. They were finally re-dried and resuspended in RPMI 10% 
FBS at appropriate concentrations to be used in functional assays. 
To facilitate solubilizing of lipid extracts in aqueous medium, the 
samples were dissolved first in a minimum volume of methanol.
statistical analysis
Values are expressed as the mean  ±  SEM, and significant 
differences were determined using either Mann–Whitney 
4Belo et al. L. infantum Exoproducts and NKT Cells
Frontiers in Immunology | www.frontiersin.org June 2017 | Volume 8 | Article 710
non-parametric t-tests or ANOVA with 95% confidence interval 
(GraphPad Prism 6). p-Values (p < 0.05) were considered signi-
ficant. *p < 0.05, **p < 0.01, ***p < 0.001.
resUlTs
L. infantum exoproducts inhibit  
inKT cell expansion
Previous reports support a possible influence of iNKT cells on 
the outcome of experimental Leishmania infection (38, 39). 
However, there are only few data documenting their impact 
on the severity of the human pathology. Our expertise in 
preparing exoproducts as well as EV and VDE fractions (6), 
together with the human iNKT  cell expansion protocol cur-
rently used in our laboratory (18, 19), enabled us to examine 
how L. infantum Exo affected the functional properties 
of these lymphocytes. iNKT  cells were identified by their 
expression of CD3 and CD1d-tetramers loaded with PBS57 
antigen (α-GalCer analog), as previously described (18, 19). 
PBMCs isolated from healthy donors were cultured with 
α-GalCer alone or together with L. infantum Exo, EV, VDE, 
or heterologous EV (hEV) used as a negative control. Exo, 
as well as VDE and EV significantly impaired the expansion 
of iNKT  cells (Figures  1A,B), while unrelated hEV had no 
effect (Figures 1A,B). L. infantum Exo, EV, and VDE targeted 
iNKT  cells specifically since the frequency of conventional 
CD4+ and CD8+ T  cells was not modified under these cul-
ture conditions (Figure 1C). Moreover, a possible toxicity of 
L. infantum extracts could be ruled out because total cell 
viability was not impaired (Figure 1D).
These findings clearly establish that L. infantum Exo, EV, and 
VDE fractions inhibit human peripheral blood iNKT cell expan-
sion without affecting the frequency of conventional CD4+ and 
CD8+ T lymphocytes.
L. infantum exoproducts impair  
cytokine Production by inKT cells
Invariant Natural Killer T  cells are known for their ability to 
promptly and massively secrete cytokines when stimulated. 
To investigate how L. infantum Exo, EV, and VDE fractions 
affected this biological activity, we took advantage of a human 
polyclonal primary iNKT cell line instead of the heterogeneous 
in vitro expanded PBMC population. These cells were co-cultured 
with CD1d-transfected C1R cells loaded with α-GalCer in the 
presence of increasing concentrations (1, 10, and 20×) of L. infan-
tum extracellular products. iNKT cell activation was assessed 40 h 
later. We validated that non-transfected C1R cells were unable 
to stimulate iNKT cells in these conditions (data not shown).
First, we ruled out a possible effect of Exo, EV, and VDE frac-
tions per se on iNKT by evaluating the secretion of GM-CSF that 
did clearly not take place in response to these compounds (Figure 
S2 in Supplementary Material). However, all three exoproducts 
inhibited the activity induced by α-GalCer in a dose-dependent 
manner (Figure  2A). The dose of 20× was the most effective 
for all compounds. Of note, a fivefold increase in α-GalCer 
concentration reversed this inhibition, except for the dose of Exo 
20× (Figure  2B). hEV had no significant effect on iNKT  cell 
activation, whatever the dose (Figures 2A,B).
Next, we tested the ability of L. infantum exoproducts to 
modulate the production of cytokines by iNKT cells exposed for 
a short period to α-GalCer. To this end, CD1d-transfected C1R 
cells were loaded for 2 h with α-GalCer with or without Exo, 
EV, and VDE fractions at the dose of 20×. After extensive wash-
ings, iNKT  cells were added to the culture for 5  h. All three 
compounds inhibited IL-4 and IFNγ production in response 
to α-GalCer (5 ng/ml), as shown in Figures 2C,E. The inhibi-
tion of IFN-γ secretion by EV was less pronounced, while Exo 
and VDE remained significant throughout (Figures  2C,E). 
Higher doses of α-GalCer (25 ng/ml) restored the production 
of IL-4 by iNKT  cells partially and that of IFNγ completely 
(Figures  2D,E). hEV had no effect whatsoever whether 
α-GalCer was used at 5 or 25  ng/ml (Figures  2C–E). Exo, 
EV, and VDE fractions were unable to stimulate IFNγ and 
IL-4 production by iNKT  cells when incubated with CD1d-
transfected C1R cells in the absence of α-GalCer (Figure S3 in 
Supplementary Material).
Overall, these results suggest that Exo, EV, and VDE frac-
tions might prevent optimal presentation of α-GalCer by CD1d 
molecules either directly by competing for α-GalCer-binding 
sites or indirectly by downregulating CD1d expression by trans-
fected C1R cells.
L. infantum exo, eV, and VDe Fractions 
exert a Direct effect on cD1d Binding
To asses whether L. infantum exoproducts inhibited α-GalCer 
binding to CD1d molecules directly, we used a cell-free system 
of stimulation in which plate-bound mCD1d were loaded with 
α-GalCer with or without increasing doses (1, 10, and 20×) of 
Exo, EV, and VDE fractions. Following extensive washings, we 
added 24.8 iNKT hybridoma cells and assessed their activa-
tion by measuring IL-2 levels in supernatants. As shown in 
Figure  3A, IL-2 secretion in response to 25  ng/ml α-GalCer 
was significantly inhibited by all three fractions at doses of 
10× and 20×. Note that the inhibition was completely abro-
gated when α-GalCer was added before (Figure 3B), and not 
after (Figure 3C), L. infantum Exo, EV, and VDE fractions. A 
similar reversal occurred when α-GalCer was used at a fourfold 
higher dose (Figure 3D). In none of these conditions, did hEV 
modify IL-2 production by α-GalCer-stimulated iNKT  cells 
(Figures  3A,D), which was also not altered in response to L. 
infantum Exo, EV, and VDE fractions per  se (Figure S4A in 
Supplementary Material).
To further strengthen these results, we used the L363 mAb, 
which specifically recognizes CD1d:α-GalCer complexes to 
quantify these interactions (40). We found a clear inhibition of 
complex formation in response to increasing doses of L. infantum 
Exo and VDE fractions (Figures  3E,F). Note that exoproducts 
did not alter the expression of CD1d by BM-DC, which further 
excludes an indirect effect via receptor downmodulation (Figure 
S4B in Supplementary Material).
FigUre 1 | Invariant natural killer T (iNKT) cell expansion was impaired in the presence of Leishmania infantum Exo, extracellular vesicle (EV), and vesicle-depleted-
exoproducts (VDEs). (a) Representative FACS profile showing the gating strategy used to identify iNKT cells following 8–12 days of culture with α-GalCer alone 
(control) or together with L. infantum Exo, EV, VDE, or hEV. iNKT cells were identified as CD3+ CD1d-tetramer+ cells. (B) Histograms represent the percentage of 
iNKT cells, as described in (a). (c) Representative FACS profile showing the gating strategy used to identify CD4+ and CD8+ conventional T cells among CD3+CD1d 
tetramer− peripheral blood mononuclear cell (PBMC) after 8–12 days of culture in the presence of α-GalCer. Histograms represent the percentage of CD4+ and CD8+ 
T cells among CD3+CD1d tetramer− cells. (D). Histograms represent the percentage of living cells, detected by 7AAD staining, among whole PBMC cultured in the 
presence of α-GalCer. Data are shown as means ± SEM (n = 14–24 individual donors tested). All groups were tested versus control group. *p < 0.05.
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Overall, these findings indicate that L. infantum Exo, EV, 
and VDE fractions directly block CD1d:α-GalCer complex 
formation. Furthermore, experiments with plate-bound 
CD1d do not support an indirect mechanism involving CD1d 
downregulation.
The inhibition of inKT cell activation  
by L. infantum secreted antigens is 
Mediated through lipids
In the light of the above results, we addressed the question of 
the identity of the molecules that blocked CD1d:α-GalCer 
FigUre 2 | Continued  
Leishmania infantum Exo, extracellular vesicle (EV), and vesicle-depleted-
exoproduct (VDE) altered invariant natural killer T (iNKT) cell function. The 
polyclonal human iNKT cell line was incubated with CD1d-transfected C1R 
cells alone (−) or previously loaded with α-GalCer 5 ng/ml (a,c) or 25 ng/ml 
(B,D) with (+) or without L. infantum Exo, EV, VDE, or hEV. iNKT cell 
activation was measured by assessing GM-CSF concentrations in culture 
supernatants (a,B) and by determining the percentage of IL-4+ or IFNγ+ cells 
among the iNKT cell line (c–e). Data show means ± SEM and the results are 
representative of two to three independent experiments (n = 4). All groups 
were tested versus the positive α-GalCer (+) control group. *p < 0.05, 
**p < 0.01. (e) Representative FACS profile of the results presented at (c,D).
FigUre 2 | Continued
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complex formation. Knowing that glycolipids have been identi-
fied as the major CD1d ligands (15) and that the surface of 
L. infantum is covered by a glycocalix (41), it was tempting to 
hypothesize that the lipids present in Exo, VE, and EV prepara-
tion were responsible for the inhibition of iNKT cell activation. 
Hence, we extracted total lipids from Exo, EV, and VDE fractions 
and tested them in the plate-bound CD1d assay. Figure 4A shows 
that at high doses, they were all capable of inhibiting iNKT cell 
activation.
As a proof of concept, we tested whether the lipid extracts 
could also inhibit iNKT cell expansion from total PBMC, which 
was actually the case, as depicted in Figures 4B,C.
Collectively, these data demonstrate that lipids present in 
L. infantum Exo, EV, and VDE fractions account for the inhibi-
tion of iNKT cell activation induced by whole fractions.
DiscUssiOn
Leishmaniasis remains a major public health issue because an 
effective human vaccine has not been developed so far. The most 
likely reason for this failure is that Leishmania spp. uses a variety 
of strategies to divert the immune system. Herein, we provide 
evidence for a new mechanism of evasion, which causes inhi-
bition of TCR-dependent expansion and activation of human 
iNKT cells through release of exoproducts (Exo), EVs, and VDE 
by L. infantum promastigotes.
It is now widely acknowledged that Exo and its EV fraction 
are important players in the horizontal transfer of information 
between different cells, without direct contact. In this context, EVs 
could act as messengers capable of priming host cells to facilitate 
parasite infections (42). For instance, L. infantum promastigotes 
constitutively secrete EVs in the lumen of sandfly midgut, which 
contribute to the initial infective inoculum, being co-ingested 
with the parasite during the bite that initiates the pathology (43). 
Leishmania-derived EVs can ensure the transport of parasite 
virulence factors, such as GP63 proteins, to host cells. GP63 
has previously been shown to interfere with host cell signaling 
pathways by inducing cleavage and activation of protein tyrosine 
phosphatases, downregulation of pro-inflammatory transcrip-
tion factors and kinases, and decrease of NO production, thus 
weakening antimicrobial mechanisms of defense (6, 8, 44). It 
has also been reported recently that Leishmania exosomes could 
become immunosuppressive by modulating monocyte cytokine 
responses to IFNγ (45).
The impact of Leishmania Exo on immunoregulatory T lym-
phocytes, including iNKT  cells, remains to be determined. 
The high degree of conservation between murine and human 
FigUre 3 | Leishmania infantum Exo, extracellular vesicle (EV), and vesicle-depleted-exoproduct (VDE) inhibited invariant natural killer T (iNKT) cell activation by 
plate-bound α-GalCer/CD1d complexes in a dose-dependent manner. Plate-bound mouse CD1d was loaded with a mixture of α-GalCer 25 ng/ml (a,e,F) and 
100 ng/ml (D) alone (+) or in the presence of L. infantum Exo, EV, VDE, or hEV at different doses. (B) Plate-bound mouse CD1d was loaded first with α-GalCer at 
25 ng/ml. Eight hours later, L. infantum Exo, EV, VDE, or hEV (20×) was added. (c) Plate-bound mouse CD1d was loaded with L. infantum Exo, EV, VDE, or hEV 
(20×). Eight hours later, 25 ng/ml of α-GalCer was added (second). After extensive washings, the 24.8 iNKT cell hybridoma was added and supernatants were 
recovered 20 h later. Data are expressed as means ± SEM of IL-2 levels detected in culture supernatants. Data are representative of two independent experiments 
(n = 4). All groups were tested versus positive α-GalCer (+) control group. *p < 0.05, **p < 0.01. (e) Histograms indicating MFI of L363 staining showing CD1d:α-
GalCer complexes expressed by bone marrow-derived dendritic cells unstimulated (−) or previously incubated with α-GalCer (+) or α-GalCer plus L. infantum Exo, 
EV, VDE, or hEV at distinct doses. Data are expressed as means ± SEM from three independent experiments. (F) Representative FACS profile showing the 
expression of L363 as described in (e). Data are representative of three independent experiments.
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iNKT  cell TCRs allows the same antigens presented by the 
non-polymorphic class-I-like molecule CD1d, such as α-GalCer, 
to be recognized by both species, which strongly supports an 
important biological function. iNKT  cells can be activated by 
two distinct TCR-dependent pathways, namely recognition of 
foreign (direct way) or self (indirect way) lipid agonists (46). The 
latter are induced during cell stress following injury or infec-
tion. Several microbes contain lipids that can be presented by 
CD1d molecules and directly activate iNKT cells. Examples are 
glycosphingolipids with α-linked glucuronic or galacturonic acid 
in Sphingomonas species (47) and diacylglycerols with α-linked 
glucosyl or galactosyl moieties in Borrelia burgdorferi (35) and 
Streptococcus pneumoniae (48). In addition to this pathogen, 
antigen-dependent mechanism of activation, microbes can also 
use indirect pathways to activate iNKT  cells. For instance, a 
previous report (27) has shown that L. infantum-infected DCs 
can upregulate their CD1d expression, thus becoming a target 
efficiently recognized and killed by activated IFNγ-producing 
iNKT cells. Furthermore, Leishmania mexicana lipophosphogly-
can (LPG) (49) stimulates DCs through an indirect pathway to 
produce IL-12 and IL-18 that, in turn, can induce IFN-γ produc-
tion by iNKT cells (50). Our findings indicate that L. infantum 
developed a means to evade protective immune responses by 
releasing Exo, EV, or VDE compounds to restrain the expansion 
and antigen activation of human iNKT cells.
Using plate-bound CD1d and L363 antibody to detect the 
formation of CD1d:α-GalCer complexes, we established that 
L. infantum Exo, VDE, and EV impaired iNKT  cell activation 
FigUre 4 | Continued  
Lipids from Leishmania infantum Exo, extracellular vesicle (EV), and 
vesicle-depleted-exoproduct (VDE) mimicked the inhibition of invariant natural 
killer T (iNKT) cell activation. (a) Plate-bound mouse CD1d was loaded with 
α-GalCer (25 ng/ml) solely or in the presence of distinct doses of lipid 
extracts from L. infantum Exo, EV, VDE. 24.8 iNKT cell hybridoma was added 
and IL-2 production in the supernatants was measured. Data are expressed 
as means ± SEM of IL-2 concentrations in culture supernatants. Data are 
representative of two independent experiments (n = 4). All groups were 
tested versus the positive α-GalCer (+) control group. *p < 0.05, **p < 0.01. 
(B) Representative FACS profile showing the percentage of iNKT cells 
obtained after culture of peripheral blood mononuclear cell with α-GalCer in 
the presence of total lipid extracts from L. infantum Exo, EV, VDE.  
(c) Histograms represent the percentage of iNKT cells, as described in  
(B). Data are expressed as means ± SEM and they are representative of  
two to five independent experiments.
FigUre 4 | Continued
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by preventing the binding of α-GalCer to CD1d molecules. 
This effect was abolished at higher doses or when α-GalCer was 
coated before the addition of L. infantum exoproducts revealing 
a potential competition between these compounds and α-GalCer. 
A previous report has shown that Leishmania donovani-infected 
macrophages and DCs failed to activate iNKT cells in response 
to α-GalCer (51). The explanation provided was that L. dono-
vani infection increased membrane fluidity and disrupted 
lipid rafts, which caused the relocation of CD1d molecules 
from lipid raft-rich to non-lipid raft regions, thus impairing 
antigen presentation to iNKT  cells (51). Herein, we did not 
observe significant modifications in the expression of CD1d 
molecules by BM-DC incubated with Exo, EV, or VDE fractions 
(Figure S4 in Supplementary Material) indicating that these 
L. infantum compounds might use other means to impair CD1d-
dependent iNKT  cell activation. A similar mechanism leading 
to the inhibition of iNKT cell activation was also observed with 
Globotriaosylceramide (Gb3), a glycosphingolipid that accumu-
lates in patients affected by the Fabry disease, a lysosomal storage 
disorder (52, 53).
It is important to note that lipids extracted from Exo, VDE, 
and EV mimicked the inhibition of iNKT cell activation induced 
by the whole fractions. According to previous studies, two 
main glycocalyx components of L. donovani, LPG, and glycoi-
nositolphospholipids (GIPLs), could be presented by CD1d 
molecules and activate iNKT  cells (39, 51, 54). Similar to our 
findings, LPG and GIPLs could compete with α-GalCer for bind-
ing to CD1d molecules (39). L. donovani LPG induced CD1d-
dependent IFNγ production by iNKT cells (39), in contrast with 
our findings that revealed no IFNγ, IL-4, or IL-2 production 
by iNKT  cells stimulated with L. infantum Exo, VDE, and EV 
pulsed BM-DC (Figures S3 and S4 in Supplementary Material). 
The authors hypothesized (39) that iNKT  cell activation by L. 
donovani LPG could contribute significantly to resistance in vis-
ceral leishmaniasis. We propose that L. infantum Exo, VDE, and 
EV fractions facilitate parasite evasion by impairing iNKT  cell 
proliferation and activation. A possible explanation for these dif-
ferences is that Leishmania LPG and GIPLs present an important 
polymorphism between the species (55). Another possibility is 
that molecules other than LPG and GIPLs are responsible for 
the effect we observed. Consequently, additional studies are 
required to better characterize the major lipid(s) implicated in 
this inhibitory effect and determine their molecular mechanism 
of action. It is possible that L. infantum lipids compete with the 
α-GalCer for the same position within the CD1d binding groove. 
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In this case, they would behave like iNKT cell antagonists since 
they did not induce cytokine production by iNKT  cells. Our 
results exclude the possibility that parasite products interact 
with α-GalCer itself to prevent its binding to CD1d since the 
inhibition of iNKT  cells was maintained when plate-bound 
CD1d were first incubated with Exo, EV, and VDE, washed, 
and then incubated with α-GalCer. Alternatively, L. infantum 
lipids could eventually interfere with α-GalCer presentation and 
iNKT cell activation by binding to an external site of the CD1d 
molecule.
In conclusion, we provide evidence that L. infantum exo-
products impair TCR-dependent human iNKT  cell expansion 
and modulate their immune responses. Our results support 
the conclusion that L. infantum Exo, EV, and VDE fractions 
should be considered as parasite virulence factors that can down-
regulate protective immunity. Therefore, a better understanding 
of their contribution to Leishmania infection spread and of the 
regulatory functions of iNKT cells may lead to advances toward 
the development of an efficient vaccine design.
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FigUre s1 | Leishmania infantum Exo, EV, and VDE preparation schema.
FigUre s2 | Leishmania infantum Exo, EV, and VDE alone did not modify iNKT 
cell function. Human iNKT cell lines were incubated with CD1d-transfected C1R 
cells alone (−) or previously loaded with α-GalCer 5 ng/ml (+) or L. infantum Exo, 
EV, VDE, or hEV. iNKT cell activation was measured by assessing GM-CSF 
concentration in culture supernatant. Data show means ± SEM, and the results 
are representative of two independent experiments (n = 4). All groups were tested 
versus the negative (−) control group (**p < 0.01).
FigUre s3 | Leishmania infantum Exo, EV, and VDE alone were unable to 
influence IL-4 and IFNγ production by iNKT cells. Histograms represent the 
percentage of IL-4+ (top panel) or IFNγ+ (bottom panel) among iNKT cell line 
following stimulation by solely CD1d-transfected C1R cells (−) or previously 
loaded with α-GalCer 5 (+) or L. infantum Exo, EV, VDE, or hEV. Data show 
means ± SEM, and the results are representative of three independent 
experiments. All groups were tested versus positive (−) control group (**p < 0.01).
FigUre s4 | Leishmania infantum Exo, EV, and VDE alone failed to inhibit iNKT 
cell activation in a CD1d dose-dependent manner. (a) Plate-bound mouse CD1d 
was loaded with a mixture of α-GalCer 25 and 100 ng/ml or L. infantum Exo, EV, 
VDE, or hEV at distinct doses. 24.8 iNKT cell hybridoma was added, and 
supernatants were recovered 20 h later. Data are expressed as means ± SEM of 
IL-2 levels detected in culture supernatants. Data are representative of two 
independent experiments (n = 4). All groups were tested versus negative control 
(−) group (**p < 0.01). (B) Representative FACS profile showing the expression of 
CD1d at the surface of BM-DC previously incubated with α-GalCer alone 
(medium) or associated with L. infantum Exo, EV, VDE, or hEV. Data are 
representative of three independent experiments.
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